leon-nanodrugs GmbH
PrivateLast Round
VC Round
Feb 12, 2026
Total Funding Raised
$20.35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
leon-nanodrugs GmbH is a pharmatech company that develops and markets devices for the encapsulation of genetic material and other active pharmaceutical ingredients into nanoparticles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
leon-nanodrugs GmbH Comparables
Compare leon-nanodrugs GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AustinPx | 81% | |
| Ascendia Pharmaceutical Solutions | 81% | |
| Phosphorex | 81% |
leon-nanodrugs GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 12, 2026 | ||||
| Series D | Aug 6, 2024 | ||||
| Series B | Apr 16, 2020 | ||||
| Series A | Jul 27, 2015 |
leon-nanodrugs GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeCare Partners | Series A |
| Eckenstein-Geigy-Stiftung | Series D, Series B |
| TVM Capital | Series D, Series B, Series A |
| CD-Venture | Series D, Series B, Series A |
| Signet Healthcare Partners | Series D, Series A |
| The Pacific Group of Companies | Series D, Series B |
| BayBG Bayerische Beteiligungsgesellschaft | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 222% MoM, reaching 1.3K.
- Jul 26, 2026
Monthly visitors grew 99% MoM.
leon-nanodrugs GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about leon-nanodrugs GmbH's valuation, stock price, and market status.
Is leon-nanodrugs GmbH a public or private company?
leon-nanodrugs GmbH is a private company.
What is the current stock price of leon-nanodrugs GmbH?
leon-nanodrugs GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is leon-nanodrugs GmbH worth (valuation)?
Valuation information for leon-nanodrugs GmbH is not publicly available.
Can I buy leon-nanodrugs GmbH stock?
leon-nanodrugs GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was leon-nanodrugs GmbH's last funding round?
leon-nanodrugs GmbH's most recent funding round was Series D on August 6, 2024.
Who are the main investors in leon-nanodrugs GmbH?
Key investors in leon-nanodrugs GmbH include TVM Capital, LBBW Venture Capital.
Will leon-nanodrugs GmbH IPO soon?
No public IPO plans have been announced for leon-nanodrugs GmbH.
How can I track leon-nanodrugs GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor leon-nanodrugs GmbH's secondary market activity and sign up for updates.